LLY

973.04

-1.5%↓

JNJ

221.62

-0.89%↓

ABBV

202.98

-0.73%↓

UNH

367.52

+0.04%↑

AZN

181.15

-1.71%↓

LLY

973.04

-1.5%↓

JNJ

221.62

-0.89%↓

ABBV

202.98

-0.73%↓

UNH

367.52

+0.04%↑

AZN

181.15

-1.71%↓

LLY

973.04

-1.5%↓

JNJ

221.62

-0.89%↓

ABBV

202.98

-0.73%↓

UNH

367.52

+0.04%↑

AZN

181.15

-1.71%↓

LLY

973.04

-1.5%↓

JNJ

221.62

-0.89%↓

ABBV

202.98

-0.73%↓

UNH

367.52

+0.04%↑

AZN

181.15

-1.71%↓

LLY

973.04

-1.5%↓

JNJ

221.62

-0.89%↓

ABBV

202.98

-0.73%↓

UNH

367.52

+0.04%↑

AZN

181.15

-1.71%↓

Начало・Списък с акции・Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Отворен

СекторЗдравеопазване

18.47 1.65

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

17.7

Максимум

18.87

Ключови измерители
By Trading Economics
Приходи	21M -589K
Продажби	41M 290M
Марж на печалбата	-0.203
Служители	2,500
EBITDA	30M 11M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+62.05% upside

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	76M 1.4B
Предишно отваряне	16.82
Предишно затваряне	18.47

Настроения в новините

By Acuity

60%

40%

299 / 347 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

21.29 / N/A Подкрепа & съпротива

Tandem Diabetes Care Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.05.2026 г., 23:41 ч. UTC

Печалби

Arm Holdings Lacks Supply to Meet Roaring Demand for New Chips -- Update

6.05.2026 г., 21:40 ч. UTC

Печалби

Nutrien Logs Higher Profit, Sales Growth in 1Q

6.05.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

6.05.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Prices Steady, Supported by Lower U.S. Treasury Yields -- Market Talk

6.05.2026 г., 23:13 ч. UTC

Печалби

Kakao 1Q Net Profit Beat FactSet-Compiled Consensus

6.05.2026 г., 23:13 ч. UTC

Печалби

Kakao 1Q Net KRW226.84B Vs. Net KRW200.33B >035720.SE

6.05.2026 г., 23:12 ч. UTC

Печалби

Kakao 1Q Oper Pft KRW211.40B Vs. Pft KRW105.40B >035720.SE

6.05.2026 г., 23:11 ч. UTC

Печалби

Kakao 1Q Rev KRW1.942T Vs. KRW1.864T >035720.SE

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: Low Single-Digit Loan Growth Outlook for 2026 >U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: 2026 Outlook for Total Credit Costs at 25-30 Basis Points >U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: Low Single-Digit Operating Cost Growth Outlook for 2026>U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: 2026 Outlook for Full-Year NIM of 1.75%-1.80% >U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: High Single-Digit Fee Growth Outlook for 2026 >U11.SG

6.05.2026 г., 23:07 ч. UTC

Печалби

United Overseas Bank: 1Q Net Profit Decline Reflects Softer Operating Environment >U11.SG

6.05.2026 г., 23:06 ч. UTC

Печалби

United Overseas Bank 1Q Net Fee Income S$637M Vs. S$694M >U11.SG

6.05.2026 г., 23:06 ч. UTC

Печалби

United Overseas Bank 1Q Net Interest Income S$2.32B Vs. S$2.41B >U11.SG

6.05.2026 г., 23:05 ч. UTC

Печалби

United Overseas Bank 1Q Net S$1.44B Vs. Net S$1.49B >U11.SG

6.05.2026 г., 23:04 ч. UTC

Печалби

United Overseas Bank 1Q Total Income S$3.42B Vs. S$3.66B >U11.SG

6.05.2026 г., 22:50 ч. UTC

Печалби

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

6.05.2026 г., 22:25 ч. UTC

Пазарно говорене

Canada's Public Finances on Sustainable Path, BOC's Macklem Says -- Market Talk

6.05.2026 г., 22:11 ч. UTC

Печалби

Taseko Mines Ltd. 1Q Adj EPS C$0.08 >TKO.LN

6.05.2026 г., 22:11 ч. UTC

Печалби

Taseko Mines Ltd. 1Q EPS C$0.05 >TKO.LN

6.05.2026 г., 22:05 ч. UTC

Пазарно говорене

Updated Govt Fiscal Plan Won't Have Sizable Impact on BOC Outlook -- Market Talk

6.05.2026 г., 21:58 ч. UTC

Печалби

Arm Stock Takes Wild Ride After Earnings. Demand Might Be Too Strong to Meet. -- Barrons.com

6.05.2026 г., 21:47 ч. UTC

Пазарно говорене

Печалби

Costco Posts 13% Sales Growth in April -- Market Talk

6.05.2026 г., 21:46 ч. UTC

Печалби

IonQ Doubles Down on Nvidia Comparison. Why the Stock Is Falling After Blowout Earnings. -- Barrons.com

6.05.2026 г., 21:40 ч. UTC

Печалби

Arm Stock Takes Wild Ride After Earnings. Demand Might Be Too Strong to Meet. -- Barrons.com

6.05.2026 г., 21:35 ч. UTC

Пазарно говорене

BOC's Macklem Defends Warning About Rate Hikes to Fight Inflation -- Market Talk

6.05.2026 г., 21:32 ч. UTC

Горещи акции

Stocks to Watch Wednesday Recap: Advanced Micro Devices, Flutter, Disney, Uber -- WSJ

6.05.2026 г., 21:29 ч. UTC

Печалби

Fastly Stock Tumbles. An Earnings Beat Pauses a Monster Rally. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Tandem Diabetes Care Inc Прогноза

Ценова цел

By TipRanks

62.05% нагоре

12-месечна прогноза

Среден 32.2 USD 62.05%

Висок 56 USD

Нисък 22 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Tandem Diabetes Care Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

15 ratings

Купи

Задържане

Продай

Според 15 анализатори, дали борсови рейтинги на Tandem Diabetes Care Inc през последните 3 месеца.

Техническа оценка

By Trading Central

21.29 / N/AПодкрепа & съпротива

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Настроение

By Acuity

299 / 347 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.